The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells
Open Access
- 1 January 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 5 (1), 46
- https://doi.org/10.1186/1476-4598-5-46
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Epidermal Growth Factor Receptor Inhibitors in Development for the Treatment of Non–Small Cell Lung CancerClinical Cancer Research, 2006
- Front-Line Therapy of Advanced Pancreatic CancerSeminars in Oncology, 2005
- Prognostic Significance of c-kit Mutation in Localized Gastrointestinal Stromal TumorsClinical Cancer Research, 2004
- Imatinib Inhibits Proliferation of Ewing Tumor Cells Mediated by the Stem Cell Factor/KIT Receptor Pathway, and Sensitizes Cells to Vincristine and Doxorubicin-Induced ApoptosisClinical Cancer Research, 2004
- Immunohistochemical expression of receptor-tyrosine kinase c-kit protein in invasive ductal carcinoma of the pancreasAnti-Cancer Drugs, 2003
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Tyrosine Kinase Inhibition: An Approach to Drug DevelopmentScience, 1995
- W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activityNature, 1995
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.JCI Insight, 1993
- Growth factors and their action in vivo and in vitroThe Journal of Pathology, 1983